AADAT/KAT-II, an enzyme metabolizing KYN to Kynurenic acid, a key ligand for the AhR transcription factor28, was highly expressed in three of five BrCa samples, a novel finding that requires further validation. The gene discussed is AHR; the disease is invasive breast carcinoma.